Rising dispensation of prescription opioids confirmed

(Medical Xpress) -- An investigative team led by Simon Fraser University health sciences professor Benedikt Fischer has established that starkly increasing prescription of strong opioids (POs) is driving up dispensation of the painkillers in Canada.

Fischer, also the CIHR/PHAC applied public health chair, notes POs are essential medication for treating severe and chronic pain. But, in recent years, they have been associated with strongly increasing (i.e., misuse and treatment admissions) and mortality (i.e., ) in Canada.

The study, Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, analyzes dispensing data for opioids-related prescriptions. It is based on a of 2,700 retail pharmacies in 10 provinces between 2005 and 2010. The Pharmacoepidemiology and Drug Safety Journal published the study’s results online in its July 2011 issue.

Based on an analysis of defined daily doses (DDD) of weak and strong POs per 1,000 people set by the World Health Organization (WHO), Canada’s dispensation of the drugs increased by 13.1 per cent. The amount of all dispensed POs rose from 20.3 DDD/1,000 people in 2005 to 23.0 DDD/1,000 people in 2010.

While the volume of dispensed strong POs rose by 42.1 per cent (7.6 to 10.8 DDD/1,000 people), the volume of weak ones dropped slightly by 4.4 per cent (12.7 to 12.2 DDD/1,000 people).

Based on WHO standards, the researchers defined strong POs as hydrocodone, hydromorophone, oxycodone, fentanyl, meperidine, methadone and morphine. The WHO defines codeine and its combination products as weak POs.

The research team included SFU adjunct professor Wayne Jones from the Centre for Applied Research in Mental Health and Addiction (CARMHA) and University of Toronto researchers Murray Krahn and Juergen Rehm.

North America has the highest POs-dispensation rate in the world and previous studies indicate increased dispensation of the is linked to increased POs-related illnesses and deaths. Governments are developing policy measures on how to reduce POs-related harms to public health. They include improved prescription monitoring and guidelines for opioids.

Given harm-related issues and that little is known about why POs dispensation is increasing, the study has a warning.

“Canada currently finds itself at a major policy and practice development juncture in regard to opioid use that, on the one hand, ought to maximize availability of opioid-supported care for chronic and severe pain with optimal standards and outcomes, while minimizing rapidly rising opioid-related problems and harms...

“The quantity and quality of opioids dispensed — different as these are between Canadian provincial jurisdictions — undoubtedly constitute a crucial variable in this challenge, yet key data are currently missing to guide decision making on the basis of evidence. This issue urgently requires further targeted investigation.”

Provided by Simon Fraser University

not rated yet
add to favorites email to friend print save as pdf

Related Stories

High-dose opioid prescribing continues to climb

Sep 12, 2014

High-dose opioid prescribing increased by 23 per cent in Canada between 2006 and 2011, despite clinical guidelines recommending that most patients should avoid high-doses of these drugs, according to new ...

Noodles: Friend or foe? S. Koreans defend diet

Aug 21, 2014

Kim Min-koo has an easy reply to new American research that hits South Korea where it hurts—in the noodles. Drunk and hungry just after dawn, he rips the lid off a bowl of his beloved fast food, wobbling ...

An approach to fighting the Ebola virus

Aug 21, 2014

Terrible suffering in Western Africa has refocused the world's attention on Ebola viruses, for which there is no vaccine or cure. The viruses are masters of their attack, but researchers are working hard to fight them, said ...

Perampanel for epilepsy: Still no proof of added benefit

Aug 19, 2014

The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures). In a new early benefit assessment ...

Recommended for you

Study highlights concern for homeless seniors

15 minutes ago

A new study for the Greater Victoria Coalition to End Homelessness, co-authored by researchers at the University of Victoria and Simon Fraser University, has found that a disproportionate number of people chronically staying ...

Mateship key to boosting resilient youth

46 minutes ago

Having a supportive friend who is connected to their family and greater community can be the critical factor that protects and promotes resilience in vulnerable Aboriginal youth, according to research from ...

Here's to wine, chocolate and a long, healthy life

2 hours ago

Jeanne Calment, who died in 1997 at the age of 122, remains the oldest person on record. One might assume that she led a faultless, healthy lifestyle. Not at all. Every year on her birthday, as her celebri ...

Experts discuss communications gap on vaccines

3 hours ago

The number of parents who refuse to vaccinate their children is on the rise, and with it the incidence of preventable diseases such as measles. The health community could reverse the trend by doing a better ...

User comments